Medtronic and Nvidia plan to collaborate on integrating artificial intelligence (AI) software applications into Medtronic's GI Genius intelligent endoscopy module.
Developed and manufactured by Cosmo Pharmaceuticals, GI Genius is the first AI-assisted colonoscopy tool approved by the U.S. Food and Drug Administration (FDA) to help physicians detect polyps that can develop into colorectal cancer, the companies said.
GI Genius has been designed to host a suite of AI algorithms. Integrating Nvidia's Clara healthcare platform, for instance, could allow Medtronic to scale development of algorithms for real-time procedures, potentially accelerating AI innovation for better patient care, Medtronic noted.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
